Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Immunocore Holdings plc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- −13 vs. Q3 2024
- Shares held
- 45.4M
- +116.1K (+0.3%) vs. Q3 2024
- Total value
- $1.34B
- −$69.8M (−5.0%) vs. Q3 2024
- New holders
- 14
- 37 more added
- Sold out
- 27
- 44 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $1.65B |
| Q1 2026 | 142 | $1.58B |
| Q4 2025 | 149 | $1.79B |
| Q3 2025 | 133 | $1.79B |
| Q2 2025 | 134 | $1.50B |
| Q1 2025 | 117 | $1.40B |
| Q4 2024 | 116 | $1.34B |
| Q3 2024 | 130 | $1.41B |
| Q2 2024 | 139 | $1.46B |
| Q1 2024 | 149 | $2.68B |
| Q4 2023 | 133 | $2.56B |
| Q3 2023 | 125 | $1.92B |
| Q2 2023 | 120 | $2.12B |
| Q1 2023 | 109 | $1.61B |
| Q4 2022 | 104 | $1.73B |
| Q3 2022 | 86 | $1.25B |
| Q2 2022 | 66 | $784.5M |
| Q1 2022 | 57 | $590.1M |
| Q4 2021 | 49 | $642.4M |
| Q3 2021 | 47 | $617.4M |
| Q2 2021 | 45 | $561.1M |
| Q1 2021 | 41 | $597.8M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Immunocore Holdings plc; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 573,362 | $16.9M | 0.01% | −103,269−15.3% | Reduced |
| Two Sigma Advisers, LP | 604,900 | $17.8M | 0.04% | −152,800−20.2% | Reduced |
| Citigroup Inc | 632,944 | $18.7M | 0.02% | +616,912+3,848.0% | Added |
| Fiera Capital Corp | 779,964 | $23.0M | 0.07% | −65,768−7.8% | Reduced |
| Armistice Capital, LLC | 1,200,000 | $35.4M | 0.82% | −64,000−5.1% | Reduced |
| Bellevue Group AG | 1,205,464 | $35.6M | 0.68% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 1,225,576 | $36.2M | 2.38% | +1,225,576 | New |
| General Atlantic LLC | 1,261,684 | $37.2M | 1.32% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,515,318 | $44.7M | 0.48% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,555,600 | $45.9M | 3.04% | +450,000+40.7% | Added |
| Price T Rowe Associates Inc | 2,187,530 | $64.5M | 0.01% | +29,832+1.4% | Added |
| Primecap Management Co | 2,668,550 | $78.7M | 0.06% | +196,530+8.0% | Added |
| FMR LLC | 4,817,699 | $142.1M | 0.01% | −18,341−0.4% | Reduced |
| RTW Investments, LP | 4,869,798 | $143.7M | 2.17% | 00.0% | Unchanged |
| Wellington Management Group LLP | 6,617,055 | $195.2M | 0.04% | −431,778−6.1% | Reduced |
| T. Rowe Price Investment Management, Inc. | 6,700,208 | $197.7M | 0.12% | +200,373+3.1% | Added |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −112,199−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −101,942−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −92,257−100.0% | Sold out |
| Pier Capital, LLC | 0 | $0 | 0.00% | −82,480−100.0% | Sold out |
| HealthInvest Partners AB | 0 | $0 | 0.00% | −54,060−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −24,304−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −23,755−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −18,922−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −18,550−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −18,288−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −13,213−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −13,039−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −11,345−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −8,707−100.0% | Sold out |
| Robeco Institutional Asset Management B.V. | 0 | $0 | 0.00% | −8,324−100.0% | Sold out |
| Oppenheimer Asset Management Inc. | 0 | $0 | 0.00% | −8,045−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −6,479−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −1,303−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −617−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −269−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −167−100.0% | Sold out |
| Householder Group Estate & Retirement Specialist, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Wolff Wiese Magana LLC | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| Park Place Capital Corp | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Connective Portfolio Management, LLC | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| PEAK6 Investments LLC | – | – | – | – | Not filed |